Aslanidis C, de Jong P J, Schmitz G
Institute for Clinical Chemistry, University of Regensburg, Germany.
PCR Methods Appl. 1994 Dec;4(3):172-7. doi: 10.1101/gr.4.3.172.
The ligation-independent cloning of PCR products (LIC-PCR) is a versatile and highly efficient cloning procedure resulting in recombinant clones only. Recombinants are generated between PCR products and a PCR-amplified vector through defined complementary single-stranded (ss) ends artificially generated with T4 DNA polymerase. This procedure does not require restriction enzymes, alkaline phosphatase, or DNA ligase. The primers used for amplification contain an additional 12-nucleotide sequence at their 5' ends that is complementary in the vector- and insert-specific primers. The (3'-->5') exonuclease activity of T4 DNA polymerase is used in combination with a predetermined dNTP (dGTP for the inserts and dCTP for the vector) to specifically remove 12 nucleotides from each 3' end of the PCR fragments. Because of the complementarity of the ends that are generated, circularization can occur between vector and insert. The recombinant molecules do not require in vitro ligation for efficient bacterial transformation. To make this technique widely applicable, we have simplified the handling of the PCR fragments prior to LIC. The PCR products do not need further purification following the T4 DNA polymerase treatment. Incubation of vector and insert PCR fragments for as little as 5 min is sufficient for a high yield of recombinants. Comparison of the transformation efficiencies using different-length LIC tails revealed that using 12-nucleotide cohesive ends produced four times more transformants than were obtained with the LIC with 10-nucleotide cohesive ends. When the LIC tails were 8 nucleotides long, no transformants were obtained. PCR fragment purification, T4 DNA polymerase treatment, and LIC is complete in < 1 hr.
PCR产物的无缝克隆(LIC-PCR)是一种通用且高效的克隆方法,只会产生重组克隆。通过用T4 DNA聚合酶人工产生的特定互补单链(ss)末端,在PCR产物和PCR扩增的载体之间产生重组体。该方法不需要限制性内切酶、碱性磷酸酶或DNA连接酶。用于扩增的引物在其5'端含有一个额外的12个核苷酸序列,该序列在载体特异性引物和插入片段特异性引物中是互补的。T4 DNA聚合酶的(3'→5')核酸外切酶活性与预定的dNTP(用于插入片段的dGTP和用于载体的dCTP)结合使用,从PCR片段的每个3'端特异性去除12个核苷酸。由于产生的末端具有互补性,载体和插入片段之间可以发生环化。重组分子不需要体外连接即可高效进行细菌转化。为了使该技术广泛适用,我们简化了LIC之前PCR片段的处理。T4 DNA聚合酶处理后,PCR产物不需要进一步纯化。载体和插入片段PCR片段孵育仅5分钟就足以获得高产率的重组体。使用不同长度LIC尾的转化效率比较表明,使用12个核苷酸的粘性末端产生的转化体比使用10个核苷酸粘性末端的LIC多四倍。当LIC尾长为8个核苷酸时,未获得转化体。PCR片段纯化、T4 DNA聚合酶处理和LIC在不到1小时内完成。